Canadian pharmaceutical company with its head office at Laval in Quebec and listed in New York and Toronto, which took the Bausch Health name in 2018 after trading as Valeant Pharmaceuticals. Makes and sells prescription and over the counter medicines in gastroenterology, dermatology, neurology and international markets, holds a majority stake in Bausch + Lomb for eye health, and runs its own manufacturing plants, research and development and regulatory and pharmacovigilance operations.
No comments available.
Leave your rating & comment